Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2008
10/21/2008US7439331 Inhibition of complement activation
10/21/2008US7439320 Cripto tumour polypeptide
10/21/2008US7439264 Therapeutic compounds
10/21/2008US7439263 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
10/21/2008US7439258 Viral polymerase inhibitors
10/21/2008US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
10/21/2008US7439247 Bicyclic pyridine and pyrimidine P38 kinase inhibitors
10/21/2008US7439242 PPARγ modulators
10/21/2008US7439063 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease
10/21/2008US7439059 Compositions and methods for activating genes of interest
10/21/2008US7438902 treating diabetes mellitus; isolating a nestin-positive pancreatic stem cell from a pancreatic islet of a donor; transferring the stem cell into the patient, wherein it differentiates into an insulin-producing cell; across allogeneic or xenogeneic barriers and graft rejection does not occur
10/21/2008CA2468847C Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
10/21/2008CA2444587C Pharmaceutical compositions of low salt polyallylamine hydrochloride
10/21/2008CA2438294C Pyridopyrimidine or naphthyridine derivative
10/21/2008CA2336624C Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties
10/21/2008CA2331408C Fatty analogues for the treatment of obesity, hypertension and fatty liver
10/21/2008CA2296012C Epothilone derivatives
10/21/2008CA2270893C N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
10/21/2008CA2205347C Lazaroids-based compositions and method for preventing adhesion formation using the same
10/21/2008CA2174472C Arylalkylpyridazinones
10/16/2008WO2008123891A1 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/16/2008WO2008123798A1 Solid nanocomposition for delivering biologically active substances
10/16/2008WO2008123759A1 N-sulphoethylnicotinamide, pharmaceutical compositions containing same and use thereof for inhibiting or preventing unwanted formation of fibrous tissue
10/16/2008WO2008123582A1 Tetrahydroisoquinoline compound
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008123417A1 Anti-fatigue agent
10/16/2008WO2008123395A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
10/16/2008WO2008123308A1 Therapeutic agent comprising vasohibin
10/16/2008WO2008123231A1 Novel cyclic staple-type oligonucleotide, and nf-κb decoy comprising the same
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008123096A1 Prophylactic agent for renal failure
10/16/2008WO2008123095A1 Prophylactic agent for heart failure
10/16/2008WO2008123093A1 Agent for prevention or treatment of iron overload
10/16/2008WO2008122513A1 Heterocycles as orexin antagonists
10/16/2008WO2008122198A1 Non-steroidal androgen acceptor regulators and their medical use
10/16/2008WO2008057337A3 Use of dipeptidyl peptidase iv inhibitors for preventing, delaying or reducing the occurance of edema
10/16/2008WO2008033858A3 Kinase inhibitors, and methods of using and identifying kinase inhibitors
10/16/2008WO2007123777A3 Inhibition of hif-1 activation for anti-tumor and anti-inflammatory responses
10/16/2008WO2007022239A3 Pharmaceutical formulations for sustained drug delivery
10/16/2008WO2006069329A3 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
10/16/2008US20080255253 Extraneous fetal urogenital sinus or tissue from under the skin
10/16/2008US20080255248 Coupling a stabilizing group-oligopeptide conjugate with the free therapeutic agent, binding with a polymeric resin forming a therapeutic agent-polymeric resin complex; high specificity of action, a reduced toxicity, an improved stability in the serum and blood
10/16/2008US20080255226 Stabilized anthocyanin compositions
10/16/2008US20080255209 Combination of a NSAID and a PDE-4 inhibitor
10/16/2008US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/16/2008US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease
10/16/2008US20080255146 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy
10/16/2008US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008US20080255095 Benzylamine analogues
10/16/2008US20080255094 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
10/16/2008US20080255079 Controlled or delayed release of nefopam; fibromyalgia, chronic fatigue syndrome, complex regional pain syndrome, irritable bowel syndrome, myofacial pain or atypical chest pain
10/16/2008US20080255059 Regulators of the hedgehog pathway, compositions and uses related thereto
10/16/2008US20080255052 Immunologic regulation by theta defensins
10/16/2008US20080255051 Use to treat dyslipidemic disorders, stroke and myocardial infarction; isolated polypeptide of given sequence; labeled peptide for use in visualization of plaque
10/16/2008US20080255042 CaSR Antagonist
10/16/2008US20080255041 Compositions and methods for treating tears, fissures, or openings in the annulus fibrosis of an intervertebral disc, for example, such as those resulting from degenerative disc disease or discectomy; enhanced healing
10/16/2008US20080255038 3-[(R)-2-(N,N-dimethylamino)ethylthio-Sar]-4-(gamma-hydroxymethylleucine)cyclosporin, for example, and pharmaceutical compositions prepared from the same, in combination with one or more NS5B polymerase inhibitors; use in treatment of hepatitis C virus; avoids need to use interferon or ribavirin
10/16/2008US20080254527 VON WILLEBRAND FACTOR (vWF) - CLEAVING PROTEASE
10/16/2008US20080254506 Claudin polypeptides
10/16/2008US20080254127 Inhalation particles incorporating a combination of two or more active ingredients
10/16/2008US20080254121 sustained release dosage form has first-layer, second-layer and inner-core containing different amounts of melatonin; controlled release for sleep; improve sleep quality, treating insomnia
10/16/2008US20080254079 Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
10/16/2008US20080254050 Immunotherapeutic comprising very small particles from neisserial outer memebrane protein and/or vascular endothelial growth factor for use in targeting a nd treating cell proliferative, inflammatory autoimmune and vision defects
10/16/2008US20080254035 Expression vector comprising lipocalin gene sequences for use in prevention and treatment of cell proliferative, inflammatory, autoimmune and cardiovascular disorders
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254008 Expression vector comprising lentiviral long terminal repeats for use as tool in transfer and expression of heterologous genes in cells
10/16/2008US20080254007 Human Mesenchymal Progenitor Cell
10/16/2008US20080254005 Using antiinflammatory and angiogenic mesenchymal stem cells cultures to treat prevasive developmental disorders
10/16/2008US20080253966 Diagnostic, Prognostic, and Therapeutic Factor Smac/Diablo in Human Cancer
10/16/2008US20080253962 Irta-4 Antibodies and Their Uses
10/16/2008US20080253961 Drug delivery; biocompatable polyesters; biodegradable glycolic acid-lactic acid nanoshell (PLGA); controlled release
10/16/2008CA2681861A1 Ornithine derivative
10/16/2008CA2681746A1 Prophylactic agent for heart failure
10/16/2008CA2681560A1 Pteridinone derivatives for use as stearoyl coa desaturase inhibitors
10/16/2008CA2681551A1 Prophylactic agent for renal failure
10/16/2008CA2681163A1 Heterocycles as orexin antagonists
10/16/2008CA2680838A1 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient
10/15/2008EP1980618A2 Human DNASE I variants
10/15/2008EP1980265A1 Therapeutic agent
10/15/2008EP1980252A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
10/15/2008EP1978983A2 Extract of dioscorea sp. and the medical uses thereof
10/15/2008EP1978808A2 Method of reversing, preventing, delaying or stabilizing soft tissue calcification
10/15/2008EP1669463B1 Casein hydrolyzate, process for producing the same and use thereof
10/15/2008EP1544199B1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor
10/15/2008EP1476423B1 Arylsulfonamidobenzylic compounds
10/15/2008EP1466614B1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon
10/15/2008EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
10/15/2008EP1444202B1 Novel metalloproteinase inhibitors
10/15/2008EP1427409B1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
10/15/2008EP1415663B1 Sustained release hgf hydrogel preparations
10/15/2008EP1411982B1 Modulators of p-selectin glycoprotein ligand 1
10/15/2008EP1411940B1 Bridged piperidine derivatives as melanocortin receptor agonists
10/15/2008EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
10/15/2008EP1383497B1 Carbonic anhydrase activators for enhancing learning and memory
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1351742B1 Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
10/15/2008EP1308439B1 Proline derivatives and use thereof as drugs
10/15/2008EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 1564